DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE
The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specificin vivoparameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
11.12.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specificin vivoparameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy. |
|---|---|
| AbstractList | The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specificin vivoparameters such as tmax, Cmax, AUCt value, mean bowel function score and/or duration of analgesic efficacy. |
| Author | Hopp, Michael Smith, Kevin Leyendecker, Petra |
| Author_xml | – fullname: Hopp, Michael – fullname: Smith, Kevin – fullname: Leyendecker, Petra |
| BookMark | eNrjYmDJy89L5WTQdfEPdnR3VXDzD_JVcPb3C3H09PP0c1fwj4h09nfx93NVcPRzUfBz9PGPAHJ4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxqbmFobmxo6ExEUoAZQAm3g |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | DARREICHUNGSFORM MIT OXYCODON UND NALOXON FORME POSOLOGIQUE CONTENANT DE L'OXYCODONE ET DE LA NALOXONE |
| ExternalDocumentID | EP3578173A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3578173A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:50:39 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3578173A13 |
| Notes | Application Number: EP20190167974 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191211&DB=EPODOC&CC=EP&NR=3578173A1 |
| ParticipantIDs | epo_espacenet_EP3578173A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20191211 |
| PublicationDateYYYYMMDD | 2019-12-11 |
| PublicationDate_xml | – month: 12 year: 2019 text: 20191211 day: 11 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | Euro-Celtique S.A |
| RelatedCompanies_xml | – name: Euro-Celtique S.A |
| Score | 3.246377 |
| Snippet | The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specificin vivoparameters such as tmax, Cmax, AUCt... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191211&DB=EPODOC&locale=&CC=EP&NR=3578173A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPktmialzkESTeJrZjdIFHiqWTzgF7aYiP-fWdDWr3obR-wj4HZ2W9n5luAGzNHG1y4OVU-KWrKoqT3titpZRimcycr06pVgnPM7cmr-ZRZWQ_mm1yYlif0qyVHRI0qUN-b9rxe_TxiBW1s5fpWzrFp-RClXqB16BjBBwIaLRh7YSICwTTGsKTxF0-RuuiO4SNQ2lG3aEWzH76NVVLK6rdFiQ5hN8HBFs0R9KrFAPbZ5uO1AezFnb8bi53qrY-BBkJ5fwiitpgwwVN_yqf8kYjsneEieEh8HhDuP4sMKydAojBlE4rzzrZ7nIXJdoXGKfQR-ldnQOqRPZKuYzmVW6KlL3JZI3BUl5qylE4thzD8c5jzf_ou4EAJS4Vl6Pol9JuPz-oKjWsjr1uxfAOYvHnL |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3NT8IwFMBfCBrxpqgRP3swuzUK25g7EDPaTaasI2aaeSJ06xIuQGTGf9_XZaAXvfUj6Vfy-vrr63sFuLFmqIMzd0a1TYpaMsvpfd-VVJmm5dxJZdmFdnCORH_0aj2ldtqA-cYXpooT-lUFR0SJylDey2q_Xv1cYvHqbeX6Vs6xaPkQJANu1HSM8IFAY_DhwJ_EPGYGY5gyxMtAB3XpOqaHoLTjIBFWpPQ21E4pq98aJTiA3Qk2tigPoaEWbWixzcdrbdiLans3JmvRWx8B5bG2_hCktoiwWCReKELxSOL0neEghE88wYnwxnGKmWMggZ-wEcV-p9s5Tv3JdoTmCTQR_dUpkKLX70nXsR3l5qjps5ksEBz1oSbPpVPIDnT-bObsn7praI2SaDwdh-L5HPb1wuknGt3uBTTLj091iYq2lFfVEn0Db2p8tQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOSAGE+FORM+CONTAINING+OXYCODONE+AND+NALOXONE&rft.inventor=Hopp%2C+Michael&rft.inventor=Smith%2C+Kevin&rft.inventor=Leyendecker%2C+Petra&rft.date=2019-12-11&rft.externalDBID=A1&rft.externalDocID=EP3578173A1 |